Reversal of multidrug resistance in murine lymphoma cells by amphiphilic dihydropyridine antioxidant derivative

Marina Cindric, Ana Cipak, Julianna Serly, Aiva Plotniece, Morana Jaganjac, Lidija Mrakovcic, Tomislava Lovakovic, Azra Dedic, Ivo Soldo, Gunars Duburs, Neven Zarkovic, József Molnár

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Background: Multidrug resistance, the principal mechanism by which cancer cells develop resistance to chemotherapy drugs, is a major factor in the failure of many forms of chemotherapies. Aim: The aim of the study was to investigate the effect of K-2-11 on the reversal of multidrug resistance. Materials and Methods: The effects of amphiphilic dihydropyridine derivative K-2-11 were tested on MDR1-expressing mouse lymphoma cells and their parental control. The effects of K-2-11 with and without doxorubicin were studied by determination of cell viability, cell proliferation and production of reactive oxygen species. Results: K-2-11 caused complete reversal of multidrug resistance of the MDR cells, being much more efficient than the positive control verapamil. Accordingly, the cytotoxic effects of doxorubicin were enhanced by K-2-11, both in the MDR and in parental cell line, while K-2-11 alone did not affect cell viability. K-2-11 also acted as an antioxidant, reducing the cellular generation of reactive oxygen species. Conclusion: Our results indicate the high potential of K-2-11 as a novel antioxidant with potent MDR-blocking ability that should be studied further for development in adjuvant anticancer treatments.

Original languageEnglish
Pages (from-to)4063-4069
Number of pages7
JournalAnticancer Research
Volume30
Issue number10
Publication statusPublished - Oct 2010

Fingerprint

Multiple Drug Resistance
Lymphoma
Antioxidants
Doxorubicin
Reactive Oxygen Species
Cell Survival
Drug Therapy
Verapamil
Cell Proliferation
Cell Line
Pharmaceutical Preparations
1,4-dihydropyridine
Neoplasms
Therapeutics

Keywords

  • Antioxidant
  • Cancer
  • Dihydropyridine derivative
  • Doxorubicin
  • MDR reversal
  • Oxidative stress

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Cindric, M., Cipak, A., Serly, J., Plotniece, A., Jaganjac, M., Mrakovcic, L., ... Molnár, J. (2010). Reversal of multidrug resistance in murine lymphoma cells by amphiphilic dihydropyridine antioxidant derivative. Anticancer Research, 30(10), 4063-4069.

Reversal of multidrug resistance in murine lymphoma cells by amphiphilic dihydropyridine antioxidant derivative. / Cindric, Marina; Cipak, Ana; Serly, Julianna; Plotniece, Aiva; Jaganjac, Morana; Mrakovcic, Lidija; Lovakovic, Tomislava; Dedic, Azra; Soldo, Ivo; Duburs, Gunars; Zarkovic, Neven; Molnár, József.

In: Anticancer Research, Vol. 30, No. 10, 10.2010, p. 4063-4069.

Research output: Contribution to journalArticle

Cindric, M, Cipak, A, Serly, J, Plotniece, A, Jaganjac, M, Mrakovcic, L, Lovakovic, T, Dedic, A, Soldo, I, Duburs, G, Zarkovic, N & Molnár, J 2010, 'Reversal of multidrug resistance in murine lymphoma cells by amphiphilic dihydropyridine antioxidant derivative', Anticancer Research, vol. 30, no. 10, pp. 4063-4069.
Cindric M, Cipak A, Serly J, Plotniece A, Jaganjac M, Mrakovcic L et al. Reversal of multidrug resistance in murine lymphoma cells by amphiphilic dihydropyridine antioxidant derivative. Anticancer Research. 2010 Oct;30(10):4063-4069.
Cindric, Marina ; Cipak, Ana ; Serly, Julianna ; Plotniece, Aiva ; Jaganjac, Morana ; Mrakovcic, Lidija ; Lovakovic, Tomislava ; Dedic, Azra ; Soldo, Ivo ; Duburs, Gunars ; Zarkovic, Neven ; Molnár, József. / Reversal of multidrug resistance in murine lymphoma cells by amphiphilic dihydropyridine antioxidant derivative. In: Anticancer Research. 2010 ; Vol. 30, No. 10. pp. 4063-4069.
@article{3f2f6567d06a439ea0448d44ccb0299c,
title = "Reversal of multidrug resistance in murine lymphoma cells by amphiphilic dihydropyridine antioxidant derivative",
abstract = "Background: Multidrug resistance, the principal mechanism by which cancer cells develop resistance to chemotherapy drugs, is a major factor in the failure of many forms of chemotherapies. Aim: The aim of the study was to investigate the effect of K-2-11 on the reversal of multidrug resistance. Materials and Methods: The effects of amphiphilic dihydropyridine derivative K-2-11 were tested on MDR1-expressing mouse lymphoma cells and their parental control. The effects of K-2-11 with and without doxorubicin were studied by determination of cell viability, cell proliferation and production of reactive oxygen species. Results: K-2-11 caused complete reversal of multidrug resistance of the MDR cells, being much more efficient than the positive control verapamil. Accordingly, the cytotoxic effects of doxorubicin were enhanced by K-2-11, both in the MDR and in parental cell line, while K-2-11 alone did not affect cell viability. K-2-11 also acted as an antioxidant, reducing the cellular generation of reactive oxygen species. Conclusion: Our results indicate the high potential of K-2-11 as a novel antioxidant with potent MDR-blocking ability that should be studied further for development in adjuvant anticancer treatments.",
keywords = "Antioxidant, Cancer, Dihydropyridine derivative, Doxorubicin, MDR reversal, Oxidative stress",
author = "Marina Cindric and Ana Cipak and Julianna Serly and Aiva Plotniece and Morana Jaganjac and Lidija Mrakovcic and Tomislava Lovakovic and Azra Dedic and Ivo Soldo and Gunars Duburs and Neven Zarkovic and J{\'o}zsef Moln{\'a}r",
year = "2010",
month = "10",
language = "English",
volume = "30",
pages = "4063--4069",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "10",

}

TY - JOUR

T1 - Reversal of multidrug resistance in murine lymphoma cells by amphiphilic dihydropyridine antioxidant derivative

AU - Cindric, Marina

AU - Cipak, Ana

AU - Serly, Julianna

AU - Plotniece, Aiva

AU - Jaganjac, Morana

AU - Mrakovcic, Lidija

AU - Lovakovic, Tomislava

AU - Dedic, Azra

AU - Soldo, Ivo

AU - Duburs, Gunars

AU - Zarkovic, Neven

AU - Molnár, József

PY - 2010/10

Y1 - 2010/10

N2 - Background: Multidrug resistance, the principal mechanism by which cancer cells develop resistance to chemotherapy drugs, is a major factor in the failure of many forms of chemotherapies. Aim: The aim of the study was to investigate the effect of K-2-11 on the reversal of multidrug resistance. Materials and Methods: The effects of amphiphilic dihydropyridine derivative K-2-11 were tested on MDR1-expressing mouse lymphoma cells and their parental control. The effects of K-2-11 with and without doxorubicin were studied by determination of cell viability, cell proliferation and production of reactive oxygen species. Results: K-2-11 caused complete reversal of multidrug resistance of the MDR cells, being much more efficient than the positive control verapamil. Accordingly, the cytotoxic effects of doxorubicin were enhanced by K-2-11, both in the MDR and in parental cell line, while K-2-11 alone did not affect cell viability. K-2-11 also acted as an antioxidant, reducing the cellular generation of reactive oxygen species. Conclusion: Our results indicate the high potential of K-2-11 as a novel antioxidant with potent MDR-blocking ability that should be studied further for development in adjuvant anticancer treatments.

AB - Background: Multidrug resistance, the principal mechanism by which cancer cells develop resistance to chemotherapy drugs, is a major factor in the failure of many forms of chemotherapies. Aim: The aim of the study was to investigate the effect of K-2-11 on the reversal of multidrug resistance. Materials and Methods: The effects of amphiphilic dihydropyridine derivative K-2-11 were tested on MDR1-expressing mouse lymphoma cells and their parental control. The effects of K-2-11 with and without doxorubicin were studied by determination of cell viability, cell proliferation and production of reactive oxygen species. Results: K-2-11 caused complete reversal of multidrug resistance of the MDR cells, being much more efficient than the positive control verapamil. Accordingly, the cytotoxic effects of doxorubicin were enhanced by K-2-11, both in the MDR and in parental cell line, while K-2-11 alone did not affect cell viability. K-2-11 also acted as an antioxidant, reducing the cellular generation of reactive oxygen species. Conclusion: Our results indicate the high potential of K-2-11 as a novel antioxidant with potent MDR-blocking ability that should be studied further for development in adjuvant anticancer treatments.

KW - Antioxidant

KW - Cancer

KW - Dihydropyridine derivative

KW - Doxorubicin

KW - MDR reversal

KW - Oxidative stress

UR - http://www.scopus.com/inward/record.url?scp=78650232339&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650232339&partnerID=8YFLogxK

M3 - Article

VL - 30

SP - 4063

EP - 4069

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 10

ER -